1. New Technologies and Applications in Sacral Neuromodulation: An Update

   • Stefan De Wachter
   • Charles H. Knowles
   • Philip E. V. Van Kerrebroeck

   Commentary Open access 24 December 2019 Pages: 637 - 643

2. Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature

   • André Farkouh
   • Thomas Riedl
   • Alexandra Kautzky-Willer

   Review 23 December 2019 Pages: 644 - 655

3. Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

   • Daniel E. Hilleman
   • Barbara S. Wiggins
   • Michael B. Bottorff

   Review Open access 09 January 2020 Pages: 656 - 670

   

4. Analgesic Impact of Single-Shot Versus Continuous Femoral Nerve Block After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis

   • Shiyi Li
   • Jinpeng Zhou
   • Junchao Zhu

   Review 10 January 2020 Pages: 671 - 685

   

5. Peripheral Vascular Disease and Implication of Nursing Practice: A Brief Literature Review

   • Qin Fan
   • Yan Liu
   • Hongwei Lei

   Review 17 January 2020 Pages: 686 - 691

6. Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists

   • Laura Grant
   • Lotte Seiding Larsen
   • Rob Arbuckle

   Review Open access 19 January 2020 Pages: 692 - 706

   

7. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

   • Yuichi Ohashi
   • Masahiro Munesue
   • Fumiki Shimada

   Original Research Open access 13 December 2019 Pages: 707 - 717

   

8. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

   • David J. Jackson
   • Marc Humbert
   • Esther Garcia Gil

   Original Research Open access 14 December 2019 Pages: 718 - 729

   

9. Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis

   • Kirsi M. Manz
   • Klaus Fenchel
   • Wolfram C. M. Dempke

   Original Research Open access 14 December 2019 Pages: 730 - 744

   

10. The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants

    • Joseph Chen
    • Huiping Xu
    • Yazdi K. Pithavala

    Original Research 20 December 2019 Pages: 745 - 758

    

11. Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib

    • Nobuyuki Yamamoto
    • Takeshi Mera
    • Maximilian J. Hochmair

    Original Research Open access 20 December 2019 Pages: 759 - 769

    

12. Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal

    • Nermina Ferizović
    • Jade Marshall
    • Sheela Upadhyaya

    Original Research Open access 21 December 2019 Pages: 770 - 784

    

13. Treatment of Atrial Fibrillation Using Ablation Index-Guided Contact Force Ablation: A Matching-Adjusted Indirect Comparison to Cryoballoon Ablation

    • Ahmed Hussein
    • Dhiraj Gupta
    • Giuseppe Stabile

    Original Research Open access 21 December 2019 Pages: 785 - 799

    

14. Cost Assessment Modelling of Treatments for Highly Active Relapsing Multiple Sclerosis

    • Petri Mankinen
    • Tuomas Lundström
    • Elina Järvinen

    Original Research Open access 23 December 2019 Pages: 800 - 818

    

15. A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States

    • Drishti Shah
    • Xiaohui Zhao
    • Usha Sambamoorthi

    Original Research Open access 24 December 2019 Pages: 819 - 832

    

16. Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study

    • Maria Antonia González-Henares
    • Jose Luis Clua-Espuny
    • Jose Vicente Gil-Guillen

    Original Research 26 December 2019 Pages: 833 - 846

    

17. Model-Based Cost-Effectiveness Analysis of Panitumumab Plus FOLFIRI for the Second-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

    • Yin Shi
    • Xiaomin Wan
    • Liubao Peng

    Original Research 04 January 2020 Pages: 847 - 859

    

18. Screening and Follow-Up of Acute ROP: Reproducibility of Fluorescein Angiography

    • Donatella Barillà
    • Rosanna Guagliano
    • Luciano Quaranta

    Original Research 08 January 2020 Pages: 860 - 868

    

19. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

    • Sarah Naz Ali
    • Tam Dang-Tan
    • Brian Bekker Hansen

    Original Research Open access 10 January 2020 Pages: 869 - 882

20. Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

    • Jana Podhorna
    • Nadine Winter
    • Susann Walda

    Original Research Open access 13 January 2020 Pages: 883 - 893

    

21. Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

    • Jana Podhorna
    • Nadine Winter
    • Thomas Perkins

    Original Research Open access 13 January 2020 Pages: 894 - 905

    

22. Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study

    • Xin Sun
    • Fangbo Qian
    • Wen Di

    Original Research 16 January 2020 Pages: 906 - 917

    

23. Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship

    • Elizabeth D. Hermsen
    • Erina L. MacGeorge
    • Bernard M. Rosof

    Original Research Open access 17 January 2020 Pages: 918 - 932

    

24. Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database

    • Maureen J. Lage
    • Jamie Vora
    • Ramon Espaillat

    Original Research Open access 18 January 2020 Pages: 933 - 945

    

25. Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

    • Eric Nadler
    • Melissa Pavilack
    • Ancilla Fernandes

    Original Research 18 January 2020 Pages: 946 - 954

    

26. Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w

    • Jinlin Song
    • Wei Gao
    • Simran Tiwana

    Letter Open access 14 December 2019 Pages: 955 - 957

27. Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

    • Irina Proskorovsky
    • Erik Vandendries
    • Matthias Stelljes

    Letter Open access 14 December 2019 Pages: 958 - 962

28. Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”

    • Aaron Lazorwitz
    • Christina L. Aquilante
    • Stephanie Teal

    Letter Open access 24 December 2019 Pages: 963 - 964

29. Author’s Response to: ‘Letter to the Editor in Response to: “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”’

    • Pablo Zubiaur
    • Miriam Saiz-Rodríguez
    • Francisco Abad-Santos

    Letter Open access 24 December 2019 Pages: 965 - 967

    

30. Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small-Cell Lung Cancer in China

    • Lifeng Mu
    • Benhong Zhou

    Letter Open access 04 January 2020 Pages: 968 - 970

    

31. Response Letter to “Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China”

    • Haijing Guan
    • Yanan Sheng
    • Luwen Shi

    Letter Open access 04 January 2020 Pages: 971 - 972

32. Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

    • Yehuda Handelsman
    • Marcel H. A. Muskiet
    • Graydon S. Meneilly

    Correction Open access 23 December 2019 Pages: 973 - 973

33. Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease

    • Ariel Berger
    • Alex Simpson
    • Jeffrey Berger

    Correction 13 January 2020 Pages: 974 - 974

34. Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies

    • Daphne T. Adelman
    • Dirk Van Genechten
    • Wendy A. Martin

    Correction Open access 18 January 2020 Pages: 975 - 976